Kymera Therapeutics Inc. Common Stock vs Envista Holdings Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Envista Holdings Corporation Common Stock trades at $23.12 (market cap $3.64B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.4× Envista Holdings Corporation Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Envista Holdings Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Envista Holdings Corporation Common Stock for 0 Days on average.
| KYMR | NVST | |
|---|---|---|
Market Cap | $8.87B | $3.64B |
Volume | 779,107 | 2,411,697 |
Sector | Health | Health |
52-Week High | $127.31 | $30.26 |
52-Week Low | $55.80 | $18.95 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $4.10B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.
Read more on NVST →